Assenagon Asset Management
DCPH

Assenagon Asset Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Assenagon Asset Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-809,923
Closed -$12.7M – 1515
2024
Q1 		$12.7M Hold
809,923
– – 0.03% 372
2023
Q4 		$13.1M Hold
809,923
– – 0.03% 384
2023
Q3 		$10.3M Sell
809,923
-38,709
-5% -$534K 0.03% 375
2023
Q2 		$11.9M Hold
848,632
– – 0.04% 323
2023
Q1 		$13.1M Sell
848,632
-167,447
-16% -$2.8M 0.05% 320
2022
Q4 		$16.7M Sell
1,016,079
-387,742
-28% -$6.31M 0.06% 280
2022
Q3 		$26M Buy
1,403,821
+699,071
+99% +$11M 0.1% 204
2022
Q2 		$9.27M Sell
704,750
-150,949
-18% -$1.67M 0.03% 386
2022
Q1 		$7.93M Buy
855,699
+611,334
+250% +$5.2M 0.02% 426
2021
Q4 		$2.39M Buy
244,365
+219,874
+898% +$4.13M 0.01% 754
2021
Q3 		$832K Sell
24,491
-1,483
-6% -$47.3K ﹤0.01% 950
2021
Q2 		$951K Buy
+25,974
New +$1.01M ﹤0.01% 923

Other funds holding DCPH

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Assenagon Asset Management's DCPH Position: Q2 2024 in Review

Assenagon Asset Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 809,923 shares — an estimated $12.7M sold.

Assenagon Asset Management first reported a position in DCPH in Q2 2021 and held it in 12 quarters. The position peaked at $26M in Q3 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

  • Assenagon Asset Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 809,923 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $12.7M.
  • Assenagon Asset Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Assenagon Asset Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $26M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Assenagon Asset Management's 13F filing for Q2 2024, filed 18 Jul 2024.